• Sat. May 18th, 2024

Exploring the Challenges and Opportunities of Technology Transfer in Cell and Gene Therapy: Roberto Formisano, Senior Manager at AGC Biologics Shares Insights

BySamantha Jones

Mar 27, 2024
Advancements in technology transfer to a Contract Development and Manufacturing Organization

Roberto Formisano, Process Transfer Senior Manager at AGC Biologics, discusses the challenges associated with technology transfer in a video interview. He addresses the complexities involved in transferring technology from development to GMP manufacturing and from a customer to a contract development and manufacturing organization (CDMO).

During his conversation with EPR editor Caroline Peachey at Terrapin’s Advanced Therapies conference in London on 19 March, Roberto highlights the critical timelines that present the biggest challenges in the field of technology transfer. He explains how balancing the number of batches that need to be manufactured is essential to ensuring sufficient and scientifically quality data within these timelines.

Roberto also shares his insights on the technology and manufacturing trends and priorities that he foresees for the cell and gene therapy industry in 2024. He delves into the nuances of technology transfer and its implications for the industry, providing valuable insights for those looking to navigate this challenging field.

By Samantha Jones

As a dedicated content writer at newszxcv.com, I bring a passion for storytelling and a keen eye for detail to every piece I create. With a background in journalism and a love for crafting engaging narratives, I strive to deliver informative and captivating content that resonates with our readers. Whether I'm covering breaking news or delving into in-depth features, my goal is to inform, entertain, and inspire through the power of words. Join me on this journey as we explore the ever-evolving world of news together.

Leave a Reply